Mendez Rodríguez, Sariemma
Rodríguez-Hernández, Aida M.
Torres-Torres, Gabriela
Centeno-Girona, Hilmaris
Cruz-Correa, Marcia
Article History
Received: 11 January 2022
Revised: 4 May 2022
Accepted: 5 May 2022
First Online: 1 June 2022
Declarations
:
: The authors declare that no funds were received during the preparation of this manuscript and have no relevant or non-financial interests to disclose. Dr. Cruz-Correa currently serves as the CMO PanOncology Trials and is an Executive Board Member of Precision Oncology Alliance.